J. Avagliano

Real-Life Effectiveness and Safety of Risankizumab in 131 Patients Affected by Moderate-to-Severe Plaque Psoriasis: A 52-Week Retrospective Study

A. Costanzo, A. Narcisi, M. Valenti, 2022, Dermatology and Therapy.

Generalized pustular psoriasis flare in a patient affected by plaque psoriasis after BNT162b2 mRNA COVID‐19 vaccine, successfully treated with risankizumab

A. Narcisi, R. Borroni, M. Valenti, 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.

New-onset and flares of psoriasis after COVID-19 infection or vaccination successfully treated with biologics: a case series

A. Costanzo, A. Narcisi, M. Valenti, 2023, The Journal of dermatological treatment.

Real-Life Effectiveness and Safety of Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: A Single-Center 16-Week Study

A. Costanzo, A. Narcisi, M. Valenti, 2023, Dermatology and Therapy.

Upadacitinib for the Treatment of Concomitant Psoriasis and Atopic Dermatitis: a Case Series.

A. Costanzo, A. Narcisi, G. Pavia, 2023, The Journal of dermatological treatment.